Dynaris

We set new standard in oxygen therapy; 7 patents, FDA, superior therapy, & more

https://wefunder.com/dynaris

Total raised on Wefunder: 179980

Total investors: 43

Quick facts

• FDA 510 (K), EUA, ISO-13485 Quality System, FDA registered manufacturing in-house, Ready to go!
• 5.9 million patients on oxygen in the U.S. alone growing to over 7 million patients in 2023.
• Protected by 7 U.S. Patents, more pending, foreign patents pending.
• Experienced team with a history of success, from concept through acquisition. CEO has 28 patents
• Superior oxygen therapy for patients. Sets a new therapeutic standard for oxygen patients.
• Oxygen therapies are expanding to other areas; i.e. cluster headaches and wound healing treatments
• Additional products in development expand our technologies into other therapeutic market segments.

Team profiles

• Timm Eckenroth
• Ben Stockman
• Ryan Lundgren
• Oscar Carrillo
• Tabitha Cacheris
• Joshua Samuel
• Deb Aylsworth
• Alonzo C. Aylsworth

Featured investor profiles

• Richard B Feldmann